Neuroectodermal Tumors, Primitive

15 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Neuroectodermal Tumors, Primitive
Treatment and conditionWhere it standsTrials
68-Gallium DOTATATE for neuroectodermal tumors, primitivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Autologous hALK.CAR T cells for neuroblastomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
autologous NK cell plus GD2 antibody for neuroblastomaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Blood Sample + Cerebrospinal Fluid (CSF) Sample + Chemotherapy Drug, Cancer - Physician's Choice + Non-Investigational Surgical Resection + Radiotherapy (RT) + Tumor Tissue Sample + Temozolomide for neuroectodermal tumors, primitivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Chemotherapy + MAPK inhibitors + ARSENIC TRIOXIDE for neuroblastomaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Educational and Media Intervention for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Eflornithine for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Irradiation + Surgical resection + PEGFILGRASTIM + Vincristine + ETOPOSIDE + TOPOTECAN + Cyclophosphamide + Carboplatin + FILGRASTIM + CISPLATIN + Methotrexate for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Magnetic Resonance Imaging + Biopsy Procedure + Bone Marrow Aspiration + Bone Marrow Biopsy + Clinical Observation + Computed Tomography + Ultrasound + ETOPOSIDE + Doxorubicin hydrochloride + Cyclophosphamide + Carboplatin for ganglioneuroblastomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Magnetic Resonance Imaging + Clinical Observation + Computed Tomography + Ultrasound for ganglioneuroblastomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Magnetic Resonance Imaging + Laboratory Biomarker Analysis + Radiation Therapy + Vincristine + Lomustine + Cyclophosphamide + CISPLATIN + Vincristine Sulfate for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Metformin hydrochloride for medulloblastomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ommaya/VPS + Surgical resection + PEGFILGRASTIM + Vincristine + TOPOTECAN + Cyclophosphamide + Carboplatin + FILGRASTIM + CISPLATIN + Methotrexate for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Metformin for medulloblastomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Surgical resection + PEGFILGRASTIM + Vincristine + TOPOTECAN + Cyclophosphamide + Carboplatin + FILGRASTIM + CISPLATIN + Methotrexate for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1